Stock Report

Innova Captab Limited reported strong results for Q1 FY27, with Revenue from Operations at ₹ 470.9 crores and EBITDA at ₹ 75.1 crores



Posted On : 2026-08-11 22:32:09( TIMEZONE : IST )

Innova Captab Limited reported strong results for Q1 FY27, with Revenue from Operations at ₹ 470.9 crores and EBITDA at ₹ 75.1 crores

Innova Captab Limited (BSE: 544067, NSE: INNOVACAP) is a leading pharmaceutical company committed to delivering high-quality healthcare solutionsthrough a robust presence across the entire pharmaceuticals value chain, including research and development, manufacturing, distribution, marketing, and exports. The company is pleased to announce its unaudited financial results for the quarter ended June 30th, 2026.

Q1FY27 vs. Q1 FY26 Performance:

- Revenue from Operations registered strong growth of 34.0% to ₹ 470.9 crores vs. ₹ 351.5 crores
- Recorded EBITDA growth of 32.7% to ₹ 75.1 crores vs. ₹ 56.6 crores. EBITDA margin for the quarter was 16.0%
- PAT for the quarter was ₹ 44.1 crores, registering growth of 42.3%. PAT margin was 9.4%

Commenting on the company's performance, Mr. Vinay Lohariwala, Managing Director, Innova Captab Limited, said "Innova Captab Limited delivered a strong start to FY27, with revenue and EBITDA growing by 34% and 33% YoY, respectively. The performance underscores the continued strength of our diversified business model, disciplined execution and sustained customer traction across both our CDMO Services & Products and Branded Generics businesses.

Growth during the quarter was supported by steady order flows, a broader product portfolio and deeper engagement with existing and new customers. Our focus on operational excellence, manufacturing efficiency and quality continues to strengthen our competitive positioning and enables us to meet the evolving requirements of domestic and international markets. Our Jammu facility is witnessing a steady ramp-up, supported by increasing business from existing customers as well as the onboarding of new clients.

We remain committed to strengthening our position as a trusted CDMO partner while expanding our branded generics footprint across key markets. With a clear strategic roadmap, disciplined capital allocation and timely execution, we are confident of sustaining growth while enhancing profitability and delivering long-term value for our stakeholders."

Shares of Innova Captab Limited was last trading in BSE at Rs. 1021.45 as compared to the previous close of Rs. 968.25. The total number of shares traded during the day was 13759 in over 964 trades.

The stock hit an intraday high of Rs. 1029.00 and intraday low of 970.00. The net turnover during the day was Rs. 13824336.00.

Source : Equity Bulls

Keywords

InnovaCaptab Pharmaceuticals INE0DUT01020 Q1FY27 Q1FY2027 ResultUpdate